BOL-303259-X: Clinical Trials

6 trials of BOL-303259-X, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Phase 3, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2
Phase 11Completed 1

Follow BOL-303259-X: new trials by email Literature Review of BOL-303259-X trials Research Report on BOL-303259-X

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT
Latanoprostene bunod - Glaucoma, Ocular Hypertension
Phase 3CompletedBausch & Lomb Incorporated1302013-07-052018-07-26
Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers
Latanoprostene bunod - Intraocular Pressure
Phase 1CompletedBausch & Lomb Incorporated242013-07-012018-05-15
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
BOL-303259-X, Timolol - Open-Angle Glaucoma, Ocular Hypertension
Phase 3CompletedBausch & Lomb Incorporated4202013-01-312018-11-07
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
BOL-303259-X, Timolol - Open-Angle Glaucoma, Ocular Hypertension
Phase 3CompletedBausch & Lomb Incorporated4202013-01-012018-11-21
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
BOL-303259-X, Timolol maleate - Ocular Hypertension, Open Angle Glaucoma
Phase 2CompletedBausch & Lomb Incorporated252012-11-012018-09-04
Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension
BOL-303259-X, Latanoprost - Intraocular Pressure
Phase 2CompletedBausch & Lomb Incorporated4132010-12-132018-07-24

Conditions studied

Ocular Hypertension (4)  ·  Glaucoma, Open-Angle (3)  ·  Glaucoma (1)

Sponsors

Bausch & Lomb Incorporated (6)

Countries

United States (6)

Top investigators

Jason Vittitow (2)  ·  Quintus Ngumah, OD, PhD (2)  ·  Jason L. Vittitow, PhD (1)  ·  Rabia Ozden, MD (1)

Results publications

PMID 29194198, PMID 25488946, PMID 26563323, PMID 26875002, PMID 27210275, PMID 27457257, PMID 27457469